CGRP-targeted therapy fulfilling the treatment gap in medication-underuse setting: a retrospective cohort study at a tertiary headache center in Thailand, a lower-middle-income country
Discontinuation of preventive migraine treatment remains a significant issue in Thailand. CGRP mAbs were associated with higher treatment persistence and may help reduce polypharmacy in migraine management.
Authors
- Akarin Hiransuthikul (ORCID: https://orcid.org/0000-0003-1906-8171)
- Thanakit Pongpitakmetha (ORCID: https://orcid.org/0000-0002-8338-4649)
- Wanakorn Rattanawong (ORCID: https://orcid.org/0000-0001-7277-9699)
- Prakit Anukoolwittaya (ORCID: https://orcid.org/0000-0001-9440-1996)
- Sekh Thanprasertsuk (ORCID: https://orcid.org/0000-0002-0267-1372)
- Sirawit Roongrojwittayakul
Institutions
- Chulalongkorn University (TH)
- Ratchaburi Hospital (TH)
- King Mongkut's Institute of Technology Ladkrabang (TH)
Publication Details
- Journal
- The Journal of Headache and Pain
- Published
- 2025-10-17
- DOI
- https://doi.org/10.1186/s10194-025-02160-7
- Citations
- 1
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.47